Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Explore which altcoins have strong teams and performance, highlighting projects with solid development and momentum. Learn how team credibility aligns with price trends and long-term potential.
28,655 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
As the AI arms race accelerates, payroll budgets are tightening. Major firms are delaying raises and halting 401(k) m...
One in four workers faces a five-year promotions drought, a trend with broad personal-finance consequences. The study...
As policymakers migrate from restraint to regulation, Washington signals a bipartisan push for federal AI licensing, ...
The U.S. government is backing quantum startups with billions. Here’s how that move could affect stock selection, ris...
When a top executive makes bold moves with his own money, it’s hard not to notice. This article dives into what berks...
Braze stock jumped today as analysts and market sentiment converged to lift software names. This article breaks down ...
When a tech chief sells shares, investors take notice. This deep-dive explains what InterDigital's CTO's sale could m...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
Seeking reliable income you can count on for decades? This guide highlights two blue-chip picks—Coca-Cola and Procter...
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
As miners shift capital from BTC holdings to AI compute, the landscape for there bitcoin mining stocks changes. This ...